Analyst
Equibles does not estimate personal net worth.
Ekke Schutz has spoken on 2 earnings calls across 1 company, most recently for Insight Molecular Diagnostics Inc. on March 26, 2026. The companies whose calls Ekke Schutz spoke on are classified in the Healthcare sector.
“So I think this entire heart project has two big tiers. The first tier is we are going to provide data that we are generating in the near future.”
“We had, as Josh said, we had the first pre-meeting. I talked about that at the last call, what the outcome was, which was kind of a little bit in favor to us. We had this informational meeting since then we needed to understand what digital PCR is and what are the specifics.”
Diagnostics & Research · Healthcare
